GRCE
Grace TherapeuticsCNasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-06-03
+
Peers tracked
10
U.S. public peers
Grade Position
Above peers
vs peer average
GRCE vs peer average
79/100
GRCE vs. peer average (C vs. F)
Grade spread
D 2 · F 8
Graded peers loaded
Coverage
10 graded
100% of tracked
Peer overview
ICCC is the first available peer comparator.
ImmuCell is a loose peer, but it is similarly useful as a small-cap specialty-biopharma comparison where financing, execution, and liquidity can matter as much as clinical progress.
✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
GRCE
Grace Therapeutics
ICCC
ImmuCell
Grade
C
F
Momentum
70
5
Value
41
59
Sentiment
53
-
Setup Bias
Net Neutral
-
Market Cap
-
-
Posture
Mixed
Defensive
Grade position vs ICCC
GRCE / ICCC
Grade Position
Above peers
GRCE vs. peer average (C vs. F)
79/100
Momentum
70
GRCEValue
41
ICCCSentiment
53
-Rotation landscape
Peers ranked by the order returned from the peer source, with grades from the API.
Rank
Ticker
Company
Grade
Grade score
vs GRCE
ICCC is the first peer returned for this comparison set.